Age and aggressiveness of prostate cancer: analysis of clinical and pathological characteristics after radical prostatectomy for men with localized prostate cancer

• Published in: Central European journal of urology Vol. 72; no. 3; pp. 240 - 246
• Main Authors: Milonas, Daimantas, Venclovas, Zilvinas, Jievaltas, Mindaugas
• Format: Journal Article
• Language: English
• Published: Poland Polish Urological Association 01.01.2019
• Subjects: Age; Antigens; Lymphatic system; Medical prognosis; Original Paper; Patients; Prostate cancer; Studies; Urology; Hungary; age; radical prostatectomy; cancer of prostate
• ISSN: 2080-4806; 2080-4873; 2080-4873
• DOI: 10.5173/ceju.2019.1974

The aim of this study was to describe age- related prostate cancer (PCa) characteristics in men after radical prostatectomy (RP). There were 2,373 men who underwent RP for clinically localized PCa between 2002 and 2017 and had complete data that were included into the study. Among them, 315 (13.3%) men aged ≤55 years (GR-1), 1,098 (46.3%) men aged between 56 to 65 years (GR-2) and 960 (40.4%) men aged older than 65 years (GR-3) were identified. All preoperative and pathological parameters were compared between all three groups and between each group separately. High-risk prostate cancer (HRPCa) cases were analyzed separately. Regression analysis was used to evaluate the impact of age on cancer aggressiveness. Clinical stage (cT), biopsy Gleason score and D'Amico risk groups were different comparing age-related study groups (all p <0.01), respectively. Preoperatively cT1 and Gleason 6 were in the highest rate for GR-1 in comparison with GR-3: 35.9 vs. 27.1%, p = 0.003 and 65.1% vs. 56.7%, p = 0.008, respectively. Analyzing pathological parameters, only Gleason 9-10 was different between GR-1 and GR-3-3.8 vs. 7.6%, p = 0.02. There were 921 (38.8%) HRPCa cases identified. Age was a significant predictor for HRPCa (p = 0.019) in the regression analysis. The oldest men (GR-3) had up to 1.5 fold increased risk for HRPCa detection in comparison with the youngest one (p = 0.008, HR1.44. 95% CI 1.098-1.87). Younger, ≤55-year-old men, are more likely to present with less aggressive clinical and pathological PCa features in comparison with the older ones. Increasing age has a significant influence on HRPCa detection after RP.